Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2022-01-04 00:00:00 ET · period of report 2022-01-01 · accession 0001209191-22-001313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-04 | 2022-01-01 | ARWR | Hamilton James C | SVP | A - Grant | $0.00 | +55.0K | 181.2K | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-01 | A | A | 55,000 | $0.00 | 181,250 | D | — | — | (F1) Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments. (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |